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Abstract: The decrease in particle size may offer new properties to drugs. In this study, we 
investigated the size reduction influence of the acetaminophen (C8H9O2N) particles by mechani-
cal activation using a dry ball mill. The activated samples with the average size of 1 µm were 
then investigated in different time periods with the infrared (IR), inductively coupled plasma 
(ICP), atomic force microscopy (AFM), and X-ray diffraction (XRD) methods. The results of 
the IR and XRD images showed no change in the drug structure after the mechanical activation 
of all samples. With the peak height at full width at half maximum from XRD and the Scherrer 
equation, the size of the activated crystallite samples illustrated that the AFM images were 
in sound agreement with the Scherrer equation. According to the peaks of the AFM images, 
the average size of the particles in 30 hours of activation was 24 nm with a normal particle 
distribution. The ICP analysis demonstrated the presence of tungsten carbide particle impurities 
after activation from the powder sample impacting with the ball and jar. The greatest reduction 
in size was after milling for 30 hours.
Keywords: acetaminophen, mechanical activation, structure investigation, nanoparticles, 
ball mill
Introduction
Nanotechnology includes the study, control, and material construction of particles 
of 10-9 m. The significant impacts of nanotechnology have received great attention in 
various fields such as material science, medicine, electronics, optics, electrochemistry, 
and electromagnetism. The generation of nanoparticle drugs has created new perspec-
tives for pharmacology, but the successful development of this technology depends on 
exploring their properties completely. High-pressure homogenization and supercritical 
fluid processing are the technologies that are used currently or are being developed 
for nanoparticle generation.1 Using nanodrug particles has opened up a new world 
for pharmacology. For this science to become more practical we have to discover the 
characteristics of such nanoparticles.2,3 One method for the preparation of micro- and 
nanoparticles is mechanical activation. The actual process of mechanical alloying 
starts with mixing the component powders in the correct proportion and loading the 
mixture into the grinding mill along with the grinding medium – generally steel balls. 
The mixture is then milled for the desired length of time until a steady state is reached, 
ie when the composition of the powder particles are the same as the proportion of the 
components of the original mixture. The milled powder is then consolidated into a 
bulk shape and heat treated to obtain the desired microstructure and properties. Thus 
the important components of the mechanical alloying process were the raw materials, International Journal of Nanomedicine 2009:4 284
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the mill, and the process variables. Nevertheless particle size 
reduction, which increases the contact surface area between 
particles, is a direct consequence of milling. As the energy 
of the system is increases there is a concomitant decrease in 
mullitization temperatures.4 The amount of energy required to 
affect fracture is dependent on the hardness and particle size 
of the material being milled and the type of stress applied. 
According to fracture theory, the hardness of a material 
increases as its particle size decreases, as a consequence the 
milling of finer materials requires more energy and therefore 
higher impact speeds.5,6 Mechanical activation has become 
a phenomenon of general significance in pharmaceutics. 
Hüttenrauch and colleagues described the extent of activa-
tion induced by relevant processes.7 Haüsler and colleagues 
demonstrated the influence of mechanical activation on the 
physical stability of salbutamol sulphate.8
Acetaminophen plays a key role in reducing the effects 
of pain and fever and chemical methods are considered to be 
the only means for producing this type of drug.9–11 In chemi-
cal preparations of Acetaminophen particle size has been 
shown to follow a normal distribution with a mean particle 
size of 100 µm.12–14
The new size reduction method for homogenizing 
acetaminophen particles is the crystallization product of 
CO2 compact fluids which is used for the direct production 
of nanocrystalline or microsize particles. Acetaminophen 
production with CO2 compact fluids provides high uni-
formity and homogenization, however, this method is very 
expensive.9–14 The effect of mechanical activation on aceta-
minophen powders and their physicochemical properties are 
explored in this study.
Materials and methods
Materials and instruments
Pure acetaminophen powder with an average size of 1 µm 
(estimated by X-ray diffraction [XRD] and scanning elec-
tron microscopy [SEM]) was purchased from Chemi Darou 
(Tehran, Iran). In addition, distilled water and ethanol were 
used. The equipment used in this work included: a digital 
balance with a 0.01 g sensitivity (Mettler-PM-4800; Mettler-
Toledo, Columbus, OH, USA), an infrared (IR) analyzer INS 
(KBr) and a ball mill (made from tungsten carbide, (WC)). 
A measure of the impurities, produced by the balls contacting 
the inside of the mill, and drug content, from the mechanical 
activation, was estimated using inductively coupled plasma 
(ICP The particle size distribution was measured using atomic 
force microscopy (AFM) (K-Alpha, 1:5405600 wave length 
and 2θ angle radiation).
Methods
Samples of 2 g or 4 g pure acetaminophen powder were 
poured into the grinding mill with the WC balls in a ratio 
1:15 (w/w). They were then mechanically activated for 
varying periods of time (15, 30, 55, and 60 hours). All the 
samples for chemical analysis and structural investigations 
were prepared in this way.
Results
The Ir results
IR analysis revealed that the structure of the acetaminophen 
powder in the activated samples remained the same, with no 
observable changes. Figure 1 illustrates the pure, un-milled, 
acetaminophen powder samples. In Figure 1A and 1B, the 
peaks at the following wavelengths represent specific func-
tional groups contained in the acetaminophen molecule: 
at 3600 cm-1 the -OH groups; at 1200–1300 cm-1 were 
associated C=C groups; 3000 cm-1 to the N-H groups and 
at 2000 cm-1 to the C=O groups. Finally, the N-H bending 
vibration is seen at 500 cm-1 and the stretch – vibration groups 
at 1600–1400 cm-1 were attributed to the C=C groups.
The XrD results
For the XRD analysis four acetaminophen powder samples 
were tested, the normal un-milled sample together with 
the mechanically activated samples milled for 15, 30, and 
55 hours. The 15-hour mechanically activated sample and 
the normal un-milled sample demonstrated no specific 
variation in their structure. The remaining mechanically 
activated samples, those for 30 and 55 hours milling were 
investigated more thoroughly. Figure 2 represents the X-ray 
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Figure 1 The infrared images of the acetaminophen powder samples produced by 
normal size samples and produced in 30 hours of mechanical activation powder 
samples.International Journal of Nanomedicine 2009:4 285
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defraction spectra of the normal un-milled acetaminophen, 
(Figure 2A), the sample mechanically activated for 30 hours, 
(Figure 2B), and the mechanically activated sample for 
55 hours, (Figure 2C).
The maximum 2θ peak was equal to 26° and related to 
the (2-21) and (3-11) surfaces. The crystallite size of the 
three maximum peaks from right to left were associated 
with the (1-21), (2-20), (3-11) surfaces and was determined 
with the use of the Scherrer equation with the full-width at 
half-maximum (FWHM) values.
By activating FWHM, the related angle crystallite sizes 
can be determined with the Scherrer equation. Table 1 exhib-
its the FWHM, the 2θ angle and the mean particle size for the 
mechanically activated samples milled for 30 and 55 hours. 
The results are related to the three XRD maximum peak 
surfaces. However, FWHM cannot be accurately estimated 
because of the overlapping of the two peaks. The peak of 
surface (101) was estimated afterward.
The AFM results
The AFM images of the two drug samples (the 30-hour 
mechanically activated sample and the 55-hour mechanically 
activated sample) are given in Figure 3 and Figure 4. Scans 
of 5 × 5 µm and 20 × 20 µm determined the particle size 
distribution, growth, and the nature of the crystallites on mica 
surfaces. Figures 3B and 4B display the average size and the 
particle distribution for samples mechanically activated for 
30 hours and 55 hours respectively. The uniform distribution, 
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Figure 2 The X-ray diffraction peaks of the acetaminophen powder samples. 
A) Peaks of the normal size acetaminophen powder samples. B) Peaks of the reduced 
size acetaminophen powder samples for 30 hours of mechanical activation. C) Peaks 
of the reduced size acetaminophen powder samples for 55 hours of mechanical 
activation.
Table 1 The FWhM, the angles, and the sizes of the activated powder 
samples in 30 and 55 hours
Maximum peaks  
properties
30-hour activated 
samples
55-hour activated 
samples
FWhM 0.3289 0.1555
2θ angle (deg) 16.57 16.57
size (nm) 24.4 51.6
Abbreviation: FWhM, full width at half maximum.
Sample: ACT30H Scan size: 20 x 20 um. Left: topography: right: section along
the blue line.
Sample: ACT30H Scan size: 5 x 5 um. 3D – view of the surface.
Sample: ACT30H Scan size: 20 x 20 um. 3D – view of the surface.
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Figure 3 The topography and the average size distribution of the acetaminophen-
activated particles in 30 hours with the scans of 20 × 20 µm  A) and 5 × 5 µm B).International Journal of Nanomedicine 2009:4 286
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54.6 nm for the samples mechanically activated for 30 hours 
and 55 hours respectively, this was in agreement with the 
XRD results. After 55 hours of mechanical activation their 
uniformities were lost.
The IcP results
The impurity of the drug with tungsten carbide resulted 
from the collision of the drug particles with the surfaces of 
the milling jar and balls. I Tables 2 and 3, show the nature of 
these impurities, the mass and percentage of WC in the drug 
sample for samples mechanically activated for 30 hours with 
maximum reduced size by ICP.
Conclusion and discussion
The IR images showed that there were no changes in the 
acetaminophen structure. The XRD peaks also confirmed that 
there were no phase changes in the reduced size samples after 
15 and 30 hours of milling. The average crystallite size in 
the 30-hour mechanically activated samples, as compared to 
the normal un-milled and the 55-hour mechanically activated 
samples were demonstrably smaller. In the 55-hour mechani-
cally activated samples, an enlargement in the particle size 
took place, ie an increase from 24 nm in samples milled for 
30 hours to 54.6 nm for samples milled for 55 hours.
The AFM images displayed the same results with a 
higher resolution. The AFM images present the average size 
and the acetaminophen crystalline particle distribution in 
different scans. Regarding these images, the particle size of 
the 30-hour mechanically activated samples were decreased 
from the initial size (the normal un-milled samples) of 
1,000 nm to 24 nm. However, the particle size of the 
55-hour mechanically activated samples were enlarged due 
to diffusion. Grain boundary diffusion during mechanical 
activation is the dominant phenomenon, because particle 
size reduction leads to the increase in the particle surface 
area grain boundary diffusion increases which leads to grain 
growth in nanocrystalline materials.
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Sample: ACT55. Scan size: 20 x 20 um. Left: topography: right: section along the 
blue line.
Sample: ACT55. Scan size: 5 x 5 um. 3D – view of the surface.
Sample: ACT55. Scan size: 20 x 20 um. 3D – view of the surface.
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Figure 4 The topography and the average size distribution of the acetaminophen-
activated particles in 55 hours with the scans of 20 × 20 µm (A) and 5 × 5 µm (B).
growth, and size of the crystallites were determined with 
20 × 20 µm scans which are depicted in Figures 3C and 4C 
for samples mechanically activated for 30 hours and 55 hours 
respectively. The 20 × 20 µm scan was used to determine the 
mean size of the crystallites which we found to be 24 nm and 
Table 2 The amount of tungsten in the drug for normal sample 
and the best sample with reduced size
Sample  The amount of tungsten 
in the drug (g/g)
Normal –
30-hour activation 0.0001
Table 3 The percentage of impurity in the drug for normal sample 
and the best sample with reduced size
Sample  The percentage of 
impurity (g)
Normal 0.001%
30-hour activation 0.0013%International Journal of Nanomedicine 2009:4
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